Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GZR18 vs Wegovy in adult obesity or overweight
NCT07150975Phase 3Recruiting
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Sep 2025
- Primary completion
- Jun 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of bofanglutide in obesity, Overweight, sponsored by Gan & Lee Pharmaceuticals. Started Sep 2025; status: recruiting.
02
Drugs
bofanglutide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT07150975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07150975.